IN8bio, Inc.
INAB
$1.75
-$0.03-1.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.61% | 40.97% | 35.18% | 18.93% | 1.16% |
| Total Depreciation and Amortization | -23.62% | 24.25% | 5.85% | 11.96% | 6.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.75% | -18.45% | -32.98% | -34.11% | 45.89% |
| Change in Net Operating Assets | 41.67% | -177.72% | 175.51% | -30.38% | -253.60% |
| Cash from Operations | 42.33% | 35.53% | 60.58% | 16.95% | -6.97% |
| Capital Expenditure | -- | -- | -- | 54.17% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 54.17% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 42.25% | -34.48% | -19.68% | -26.59% | 9.75% |
| Issuance of Common Stock | 284.78% | 54.83% | -- | -17.01% | -84.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,041.90% | 55.87% | 1,505.42% | -16.21% | -106.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.22% | 147.94% | 109.33% | -15.47% | -50.22% |